DelveInsight's Mild Cognitive Impairment Market Insights report includes a comprehensive understanding of current treatment ...

According to DelveInsight's analysis, the mild cognitive impairment market is anticipated to increase during the forecast period (2024-2034), owing to the rise in the launch of emerging therapies ...

What I've learned from my work in this field is that having a well-crafted commercial strategy is important for companies ...

The key Ulcerative Colitis therapies expected to launch in the market include Jyseleca (filgotinib), Rinvoq (Upadacitinib), ...

Convenience-store merger and acquisition activity was extremely strong as it relates to larger transactions this past year: ...

Back in 1934, Ralph Nelson Elliott discovered that price action displayed on charts, instead of behaving in a somewhat chaotic manner, had actually an intrinsic narrative attached. Elliot saw the ...

Researchers from Southern Methodist University and the University of Michigan published a study that examines platforms' A-B ...

We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not ...

Could the S&P 500 Target 7000+ in 2025? By Avi Gilburt - Jan 06, 2025 As I run a market analysis service for over 8500 members and approximately 1000 money managers, there are a lot of things that ...

March 2024: Moleac Pte Ltd announced a study of Phase 4 clinical trials for NeuroAiD. SATURN investigates the promising role ...

See how we rate investing products to write unbiased product reviews. The U.S. stock market generally closes for major holidays like Memorial Day, Independence Day, and Thanksgiving. But not all ...

Morgan Stanley sees 83% downside on Vodafone Idea from its current market price. The brokerage gave a “Sell” rating on the stock, with a target price of Rs 2.5. “We therefore believe Zomato ...